Deep venous thrombosis prophylaxis

Neurocritical Care

Volumn 15, Issue 2, 2011, Pages 295-297

  Vespa, Paul ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anticoagulation; Heparin; Intracranial hemorrhage; Sequential compression devices

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

BRAIN HEMORRHAGE; COMPRESSION GARMENT; DEEP VEIN THROMBOSIS; DRUG EFFECT; HUMAN; INCIDENCE; MEDICAL DEVICE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SEQUENTIAL COMPRESSION DEVICE; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; THROMBOSIS PREVENTION; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT TIMING; ACUTE DISEASE; INTENSIVE CARE; METHODOLOGY; RISK FACTOR; VEIN THROMBOSIS;

ACUTE DISEASE; ANTICOAGULANTS; HUMANS; INCIDENCE; INTENSIVE CARE; RISK FACTORS; SUBARACHNOID HEMORRHAGE; VENOUS THROMBOSIS;

EID: 84855889229     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-011-9599-3     Document Type: Review

References (16)

1. Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol. 2002;88: 227-49. (Pubitemid 34302973)
2. Xin ZL, Wu XK, Xu JR, Li X. Arachnoid cell involvement in the mechanism of coagulation-initiated inflammation in the subarachnoid space after subarachnoid hemorrhage. J Zhejiang Univ Sci B. 2010;11:516-23.
3. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 2010;38(suppl 2):S26-34.
4. Ray WZ, Strom RG, Blackburn SL, Ashley WW, Sicard GA, Rich KM. Incidence of deep venous thrombosis after subarachnoid hemorrhage. J Neurosurg. 2009;110:1010-4.
5. Flemming KD, Brown RD, Wiebers DO. Subarachnoid hemorrhage. Curr Treat Options Neurol. 1999;1:97-112.
6. Agnelli G. Prevention of venous thromboembolism after neurosurgery. Thromb Haemost. 1999;82:925-30.
7. Fiehler J, Ries T. Prevention and treatment of thromboembolism during endovascular aneurysm therapy. Klin Neuroradiol. 2009;19:73-81.
8. Raslan AM, Fields JD, Bhardwaj A. Prophylaxis for venous thrombo-embolism in neurocritical care: A critical appraisal. Neurocrit Care. 2010;12:297-309.
9. Collen JF, Jackson JL, Shorr AF, Moores LK. Prevention of venous thromboembolism in neurosurgery: A metaanalysis. Chest. 2008;134:237-49.
10. Grunwald IQ, Romeike BF, Roth C, Struffert T, Eymann R, Reith W. Anticoagulation regimes and their influence on the occlusion rate of aneurysms: An experimental study in rabbits. Neurosurgery. 2005;57:1048-55.
11. Grunwald IQ, Papanagiotou P, Politi M, Struffert T, Roth C, Reith W. Endovascular treatment of unruptured intracranial aneurysms: Occurrence of thromboembolic events. Neurosurgery. 2006;58:612-8.
12. Kim GH, Hahn DK, Kellner CP, et al. The incidence of heparininduced thrombocytopenia Type II in patients with subarachnoid hemorrhage treated with heparin versus enoxaparin. J Neurosurg. 2009;110:50-7.
13. Mack WJ, Ducruet AF, Hickman ZL, et al. Doppler ultrasonography screening of poor-grade subarachnoid hemorrhage patients increases the diagnosis of deep venous thrombosis. Neurol Res. 2008;30:889-92.
14. Pelz DM, Lownie SP, Fox AJ. Thromboembolic events associated with the treatment of cerebral aneurysms with Guglielmi detachable coils. Am J Neuroradiol. 1998;19:1541-7. (Pubitemid 30431051)
15. Qureshi AI, Luft AR, Sharma M, Guterman LR, Hopkins LN. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part II- clinical aspects and recommendations. Neurosurgery. 2000;46:1360-75.
16. Ross IB, Dhillon GS. Ventriculostomy-related cerebral hemorrhages after endovascular aneurysm treatment. Am J Neuroradiol. 2003;24:1528-31. (Pubitemid 37151713)